查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1133511

全球醫用氧氣市場-2022-2029

Global Medical Oxygen Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場動態

全球醫用氧氣市場正在增長，原因包括哮喘、慢性阻塞性肺病和肺癌等呼吸系統疾病的發病率不斷上升，這些疾病可能導致嚴重的健康問題甚至死亡。

預計呼吸系統疾病發病率的上升和技術進步的激增將推動市場的增長。

推動市場增長的主要驅動力是科技進步、呼吸系統疾病發病率增加和新產品推出的增加。

根據世界衛生組織 (WHO) 2022 年報告，2019 年慢性阻塞性肺病 (COPD) 導致約 323 萬人死亡，成為全球第三大死因。我來了。大約 90% 的 70 歲以下 COPD 死亡發生在低收入和中等收入國家。醫用氧氣市場受到呼吸系統疾病日益流行和全球各種新技術改進的推動。各種類型的呼吸系統疾病，如哮喘、肺癌、肺炎和慢性阻塞性肺病，對於可以通過藥物治療控製或預防的疾病和可能致命的疾病，都有不同的危險因素。據說慢性肺病如慢性阻塞性肺病和肺炎在老年人中的患病率很高，因為呼吸肌力量會隨著年齡的增長而下降。

吸煙和吸煙等生活方式的改變正在增加慢性阻塞性肺病 (COPD) 和哮喘的患病率。慢性阻塞性肺病 (COPD) 是一種危及生命的進行性慢性肺部疾病，會導致呼吸困難，並且容易惡化和出現嚴重疾病。根據世界衛生組織 (WHO) 的數據，到 2020 年，全球將有約 2.51 億人受到慢性阻塞性肺病 (COPD) 的影響。肥胖和煙草消費的增加是全球哮喘、慢性阻塞性肺病和 OSA 患病率上升的主要原因，這將推動全球醫用氧氣市場。日益嚴重的環境污染導致慢性阻塞性肺病和哮喘等呼吸系統疾病的發病率急劇上升，增加了對氧療的需求。

通過此類合作、合併或主要參與者在市場上發布新產品，已經取得了各種新穎的進展。例如，強生視力保健公司於 2021 年開發的名為 Acuvue Oasis 的醫用氧氣已獲得 FDA 批准，可提供舒適性，具有高含水量，並保持清晰的視力和眼睛健康。

與這些醫用氧氣系統相關的高成本預計將阻礙市場增長。

這些醫用氧氣系統的高成本及其維護也使其非常昂貴。在 2019 年一篇題為“氧氣設備和輸送系統”的文章中指出，“以設定的頻率重新填充液氧安置系統會產生高昂的服務成本，具體取決於氧氣流量設置和單位尺寸。有。”

COVID-19 影響分析

COVID-19 已影響到各個行業，但它是醫用氧氣市場增長的主要因素。

許多 COVID-19 病例病情嚴重，需要醫用氧氣進行治療。因此，全球對呼吸機、氧氣瓶、壁掛式製氧機和罐裝氧氣的需求猛增，不僅在醫院，而且在家庭護理中。醫用氧氣系統的需求受到 COVID-19 爆發的影響，需求增加導致全球醫用呼吸機短缺。出於這個原因，科學家和生物醫學工程師正在開發替代設備，這些設備使用現有的設備（例如氧氣濃縮器和手動復甦器）模仿呼吸機的常見功能。在美國，隨著 FDA 根據緊急使用授權計劃授權使用制氧機，預測期內對醫用氧氣設備的需求正在增加。

本報告提供大約 45 多個市場數據表、40 多個圖表和 180 頁信息。

內容

第一章研究方法與範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

第 4 章市場動態

  • 市場影響因子
    • 驅動程序
      • 呼吸系統疾病激增和家庭護理產品的演變
    • 約束因素
      • 醫用氧氣設備成本高
    • 市場機會
    • 影響分析

第五章行業分析

  • 波特五力
  • 監管分析
  • 供應鏈分析
  • 定價分析

第 6 章 COVID-19 分析

  • COVID-19 的市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章按產品類型

  • 氧氣濃縮器
  • 壓縮氧氣瓶
  • 液氧系統
  • 呼吸機
  • HFNC

第8章供氧系統

  • 低流量系統
  • 高流量系統

第 9 章不同模式的氧濃度

  • 門靜脈供氧
  • 固定式氧氣

第 10 章按應用程序

  • 肺部疾病
  • 哮喘
  • 心力衰竭
  • 囊性纖維化
  • 支氣管肺疾病
  • 其他

第 11 章，最終用戶

  • 醫院
  • 緊急醫療中心
  • 門診中心
  • 社區關懷
  • 高壓治療室
  • 居家護理
  • 其他

第 12 章按地區劃分

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第 13 章競爭格局

  • 主要發展和戰略
  • 公司份額分析
  • 產品基準
  • 值得關注的重點公司列表

第 14 章公司簡介

  • Inogen Incorporation
    • 公司概況
    • 產品組合和描述
    • 主要亮點
    • 財務摘要
  • Precision Medical, Inc.
  • ResMed Inc.
  • Besco Medical Co. Ltd.
  • Koninklijke Philips N.V
  • Luxfer Group
  • Invacare Corporation
  • O2 Concepts LLC.
  • Responsive Respiratory
  • GCE Group

第 15 章全球醫用氧氣市場-DataM

簡介目錄
Product Code: DMHOS848

Market Overview

Medical Oxygen Market size was valued US$ 2,893.53 million in 2021 and is estimated to reach US$ 5,516.82 million by 2029, growing at a CAGR of 7.47% during the forecast period (2022-2029).

Oxygen is used as a life-saving gas that plays crucial role in treatment of patients during surgery, heart failure or trauma. It is a very complex compound and its production takes place in industrial plants. Medical oxygen is the use of oxygen for medical treatment. Oxygen is taken from the air that is purified and compressed to treat patients with respiratory disorders.

Market Dynamics

The global medical oxygen market growth is driven by various factors such as rising incidences of respiratory disorders like asthma, COPD, lung cancer that may lead to severe health issues or can even result in death.

Increasing incidence of respiratory disorders and surge in technological advances are expected to drive the growth of market.

The major drivers helping in the growth of the market are the rise in the scientific and technological advances, increasing incidence of respiratory disease and increasing the novel product launch.

According to World Health Organisation report 2022, chronic obstructive pulmonary disease (COPD) in 2019 caused around 3.23 million deaths and became third main cause for global deaths. Approximately 90% of COPD deaths under 70 years of age takes place in countries with low or middle income. The medical oxygen market is being driven by the increasing prevalence of respiratory disorders and various novel technological improvements across the globe. Different types of respiratory disorders such as asthma, lung cancer, pneumonia, COPD and others have different risk factors where some can be controlled or prevented through drug therapies and others may lead to death. The prevalence of chronic lung disorders such as COPD and pneumonia is high among the older population as respiratory muscle strength decreases as age progresses.

The rising prevalence of chronic obstructive pulmonary disease (COPD) and Asthma owing to the changing lifestyle, including smoking, tobacco consumption, and others. Chronic obstructive pulmonary disease (COPD) is a progressive, chronic life-threatening lung disease that causes breathlessness and predisposes to exacerbations and serious illness. According to the World Health Organization (WHO) in 2020, around 251 million people suffer from Chronic obstructive pulmonary disease (COPD) worldwide. Obesity and increased tobacco consumption are mainly contributing to the rise in the prevalence of asthma, COPD, and OSA globally, which will fuel the global medical oxygen market. The rising environmental pollution has caused a spike in the incidence of COPD, asthma, and other respiratory diseases, leading to an increased demand for oxygen therapy.

Various novel advancements are being done by key players such collaborations, mergers or releasing new products in market. For instance, in 2021 Medical Oxygen known as Acuvue Oasys developed by Johnson and Johnson Vision Care got approved by FDA that provides comfort, have high moisture content, clear vision and maintains good health of eye.

High cost associated with these medical oxygen systems is expected to hamper the market growth.

The high cost of these medical oxygen systems and their maintenance also makes it quite expensive. In 2019 an article titled "Oxygen devices and delivery systems" stated that "There is a high service cost associated with refilling the liquid oxygen stationary systems at a set frequency, contingent on the oxygen flow setting and the unit's size".

COVID-19 Impact Analysis

COVID-19 affected all the fields but it's the main factor for growth in the market of medical oxygen

as majority of COVID-19 cases were severe and needed medical oxygen for treatment. Due to this artificial ventilation, oxygen cylinders, wall-mounted oxygen concentrators and canned oxygen demand increased suddenly in hospitals as well in home care globally. Demand of the medical oxygen systems has been impacted by COVID-19 pandemic, as demand increased and this led to the scarcity of medical ventilators worldwide. To control this, scientists and biomedical engineers have developed substitute devices that will mimic the general functions of ventilators using devices that are already available such as oxygen concentrators and manual resuscitators. In U.S., the FDA permitted using the oxygen concentrators under a program Emergency Use Authorization hence enhancing the demand of the medical oxygen devices in forecast period.

Segment Analysis

Oxygen concentrator segment is expected to hold the largest market share in global medical oxygen market

Oxygen Concentrators segment is expected to hold the largest market share in global medical oxygen market as it's the most used product worldwide. It is efficient to use hence people tend to use it and hence rise in demand. Oxygen concentrators provides oxygen-enriched air that is safe. Oxygen concentrators are devices that takes up the room air that passes through a series of filters which remove dust, bacteria and other particulates. It is a two steps concentration process where in the first step the machine forces air in one cylinder that contains semi-permeable membranes, nitrogen gets absorbed here, that leaves concentrated oxygen (90% or higher) and small amounts of other gases. At the exact time, in the second cylinder, nitrogen gets desorbed and drawn out. In second step, the task of cylinders is reversed in a timed cycle, that provides a continuous flow of oxygen to patient. General oxygen concentrator delivers the oxygen flows of around 0.5-5 L*min-1 (low-flow oxygen concentrators), but some other models can achieve up to 10 L*min-1 (high-flow oxygen concentrators). Such kind of devices are easy to carry and use.

According to an article titled "Oxygen devices and delivery systems" the portable oxygen concentrators are the latest technology for long term oxygen therapy users who desire a small, lightweight and portable oxygen solution in a compact and mobile unit. These concentrators use electrical power hence supply oxygen in unlimited amount and are more cost effective as only need charging.

There is an increase in the number of companies developing the medical oxygen systems such as Inogen Inc., Medtronic, Airgas Inc., Koninklijke Philips, Linde group, Sol groups etc are the major players that are manufacturing novel Medical Oxygen. For instance, in Apr 2020, Linde announced its novel contract with the Indian Oil Corporation Limited, India's biggest refiner that has strengthened its portfolio of extensive technology.

Geographical Analysis

North America region holds the largest market share in the global medical oxygen market

The North America region is expected to lead the market in the upcoming future. Factors such as pervasiveness of respiratory disorders such as asthma, pneumonia, lung cancer, COPD and novel developments in technology are likely to increase the market growth. Currently almost 25 million people have asthma in the United States. COPD have been diagnosed in around 14.8 million adults. Annual expenditures on health care for asthma are estimated around $20.7 billion. In U.S., the FDA permitted using the oxygen concentrators under a program Emergency Use Authorization hence enhancing the demand of the medical oxygen devices.

Major key players are developing novel scientific and advanced technologies to meet the needs of users and provide them with efficient products. For instance, in April 2019, FDA approved Supersaturated oxygen therapy introduced by TherOx that is used to treat the damaged heart tissue safely. Some of the key players are developing mobile apps for convenience of users. due to which this region holds the largest market share in global medical oxygen market.

In Feb 2021, SOL Group, manufacturer of pure medical and technical gases announced that it has acquired Air Liquide Hellas, medical gases and technical gases company operative in Greek market.

Competitive Landscape

The global orthokeratology market is highly competitive with the presence of several international and local markets. Product diversification, revenue generation, and opportunities intensify the market competition. Some of the major key players in the global medical oxygen market are Inogen Incorporation, Precision Medical, Inc., ResMed Inc., Besco Medical Co. Ltd., Koninklijke Philips N.V, Luxfer Group, Invacare Corporation, O2 Concepts LLC., Responsive Respiratory, GCE Group. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the market globally. For instance, in 2021, UNICEF collaborated with The Oxygen CoLab and NEST360 to drive the production of flexible oxygen concentrator for less resource surroundings.

The key companies are focusing on key strategies such as collaboration, acquisitions, and product launches which are boosting the growth of the market globally. For instance,

  • In Sep 2022, Responsive Respiratory, a manufacturer of high-pressure oxygen products announced its partnership agreement with Boost Oxygen, provider of products related to respiratory support. With this agreement RRI will distribute Boost Oxygen products.
  • In Apr 2021, ResMed, company that develops medical devices related to cloud connect and digital health announced its AirView expansion for the ventilation. It is a cloud-based management platform for patients of respiratory care.
  • In Jan 2021, SOL Groups increased its stake in SICGILSOL its Indian joint venture for expanding its availability in Indian market of medical and technical gases.
  • In Jun 2020, GCE Healthcare launched Clarity connect care, an online platform for monitoring on its portable oxygen concentrator Zen-O life. Zen-O-life is used for improved management of oxygen therapy of patients with chronic respiratory disease such as COPD in homecare setting.
  • In Jun 2020, Medtronic announced its partnership with Foxconn Industrial for production of ventilators. All the regulatory and quality requirements were completed by Foxconn and started Medtronic's ventilator Puritan Bennett 560 manufacturing in United States.

Key Companies to Watch

Inogen Inc.:

Overview: Inogen is a company that deals with medical technologies and manufactures various respiratory products that are generally used in homecare. Their primary products are portable oxygen concentrators that are being used for chronic respiratory conditions suffering patients as it provides long term oxygen therapy. These concentrators are being manufactured and marketed with new advancements in around 57 countries. It was founded in 2001, and is headquartered in California, U.S.

Product Portfolio:

Inogen One G5: It is a portable oxygen concentrator that provides extreme oxygen per pound. It's dense, small and lightly weighted with varying settings of flow for 1-6 that can be used 24 hours.This modal is so efficient and contains easy control functions with LCD displays that is convenient to read. For instance, in 2020 a report tiltled "Oxygen monitoring and control system" stated that "The Inogen One G5 provides 1 LPM continuous at a setting of 6 with 17 breaths minute that is very efficient as compared to others."

Key Developments: In Sep 2021, Inogen, company of medical technology with innovative respiratory products announced its agreement with Ashfield Healthcare to expand its market capabilities.

The global medical oxygen market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The surge in occurrence of the respiratory disorders and new advances in home care product
    • 4.1.2. Restraints:
      • 4.1.2.1. High cost of these medical oxygen devices
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces
  • 5.2. Regulatory Analysis
  • 5.3. Supply Chain Analysis
  • 5.4. Pricing Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type Segment
  • 7.2. Oxygen Concentrator
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Compressed Oxygen Cylinder
  • 7.4. Liquid Oxygen Systems
  • 7.5. Ventilators
  • 7.6. HFNC

8. By System of Oxygen Delivery

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By System of Oxygen Delivery
    • 8.1.2. Market Attractiveness Index, By System of Oxygen Delivery Segment
  • 8.2. Low Flow Systems
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. High Flow Systems

9. By Modal Quality

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modal Quality
    • 9.1.2. Market Attractiveness Index, By Modal Quality Segment
  • 9.2. Portal Oxygen
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Stationary Oxygen

10. By Applications

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Applications
    • 10.1.2. Market Attractiveness Index, By Applications Segment
  • 10.2. Lung Disorders
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Asthma
  • 10.4. Heart Failure
  • 10.5. Cystic Fibrosis
  • 10.6. Bronchopulmonary Disorder
  • 10.7. Other

11. By End user

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.1.2. Market Attractiveness Index, By End user Segment
  • 11.2. Hospitals
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 11.3. Emergency Medical Centers
  • 11.4. Ambulatory Centers
  • 11.5. Community Care
  • 11.6. Hyperbaric Chambers
  • 11.7. Home Care
  • 11.8. Others

12. By Region

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 12.1.2. Market Attractiveness Index, By Region
  • 12.2. North America
    • 12.2.1. Introduction
    • 12.2.2. Key Region-Specific Dynamics
    • 12.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 12.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By System of Oxygen Delivery
    • 12.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modal Quality
    • 12.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Applications
    • 12.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 12.2.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.2.8.1. U.S.
      • 12.2.8.2. Canada
      • 12.2.8.3. Mexico
  • 12.3. Europe
    • 12.3.1. Introduction
    • 12.3.2. Key Region-Specific Dynamics
    • 12.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 12.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By System of Oxygen Delivery
    • 12.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modal Quality
    • 12.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Applications
    • 12.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 12.3.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.3.8.1. Germany
      • 12.3.8.2. U.K.
      • 12.3.8.3. France
      • 12.3.8.4. Italy
      • 12.3.8.5. Spain
      • 12.3.8.6. Rest of Europe
  • 12.4. South America
    • 12.4.1. Introduction
    • 12.4.2. Key Region-Specific Dynamics
    • 12.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 12.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By System of Oxygen Delivery
    • 12.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modal Quality
    • 12.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Applications
    • 12.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 12.4.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.4.8.1. Brazil
      • 12.4.8.2. Argentina
      • 12.4.8.3. Rest of South America
  • 12.5. Asia Pacific
    • 12.5.1. Introduction
    • 12.5.2. Key Region-Specific Dynamics
    • 12.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 12.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By System of Oxygen Delivery
    • 12.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modal Quality
    • 12.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Applications
    • 12.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 12.5.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.5.8.1. China
      • 12.5.8.2. India
      • 12.5.8.3. Japan
      • 12.5.8.4. Australia
      • 12.5.8.5. Rest of Asia Pacific
  • 12.6. Middle East and Africa
    • 12.6.1. Introduction
    • 12.6.2. Key Region-Specific Dynamics
    • 12.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 12.6.4.
    • 12.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By System of Oxygen Delivery
    • 12.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modal Quality
    • 12.6.7.
    • 12.6.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Applications
    • 12.6.9. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user

13. Competitive Landscape

  • 13.1. Key Developments and Strategies
  • 13.2. Company Share Analysis
  • 13.3. Product Benchmarking
  • 13.4. List of Key Companies to Watch

14. Company Profiles

  • 14.1. Inogen Incorporation
    • 14.1.1. Company Overview
    • 14.1.2. Product Portfolio and Description
    • 14.1.3. Key Highlights
    • 14.1.4. Financial Overview
  • 14.2. Precision Medical, Inc.
  • 14.3. ResMed Inc.
  • 14.4. Besco Medical Co. Ltd.
  • 14.5. Koninklijke Philips N.V
  • 14.6. Luxfer Group
  • 14.7. Invacare Corporation
  • 14.8. O2 Concepts LLC.
  • 14.9. Responsive Respiratory
  • 14.10. GCE Group

LIST NOT EXHAUSTIVE

15. Global Medical Oxygen Market - DataM

  • 15.1 Appendix
  • 15.2 About Us
  • 15.3 Contact Us